Evaluation of Clinical Characteristics, Risk Factors and Prognosis of Herpes Zoster (Shingles) Infection in Türkiye: VARICOMP-Adult-2 Study.

IF 4.3 2区 医学 Q1 INFECTIOUS DISEASES
Ozge Ozgen-Top, Zehra Karacaer, Ece Firuze Ozkan, Hasan Selcuk Ozger, Nese Saltoglu, Nefise Oztoprak-Cuvalci, Ayse Seza Inal, Birsen Mutlu, Damla Boztas, Rehile Zengin, Alpay Azap, Sema Alp-Cavus, Ali Acar, Didem Tuba Akcalı, Irem Akdemir, Dilek Bayramgurler, Hande Berk-Cam, Ahmet Çagkan Inkaya, Dilek Dasgın, Secil Deniz, Gamze Erfan, Ozlem Guler, Nilsel Ilter, Behice Kurtaran, Zekayi Kutlubay, Selda Sayin-Kutlu, Ayse Sesin Kocagoz, Ener Cagri Dinleyici, Esin Senol
{"title":"Evaluation of Clinical Characteristics, Risk Factors and Prognosis of Herpes Zoster (Shingles) Infection in Türkiye: VARICOMP-Adult-2 Study.","authors":"Ozge Ozgen-Top, Zehra Karacaer, Ece Firuze Ozkan, Hasan Selcuk Ozger, Nese Saltoglu, Nefise Oztoprak-Cuvalci, Ayse Seza Inal, Birsen Mutlu, Damla Boztas, Rehile Zengin, Alpay Azap, Sema Alp-Cavus, Ali Acar, Didem Tuba Akcalı, Irem Akdemir, Dilek Bayramgurler, Hande Berk-Cam, Ahmet Çagkan Inkaya, Dilek Dasgın, Secil Deniz, Gamze Erfan, Ozlem Guler, Nilsel Ilter, Behice Kurtaran, Zekayi Kutlubay, Selda Sayin-Kutlu, Ayse Sesin Kocagoz, Ener Cagri Dinleyici, Esin Senol","doi":"10.1016/j.ijid.2025.108105","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>The study aimed to determine the estimated prevalence of herpes zoster (HZ) infection in the adult population in Türkiye and the rates of HZ-associated complications and risk factors.</p><p><strong>Methods: </strong>This retrospective, multicenter (n=11), cross-sectional study was conducted between January 2016 and January 2022 and included all patients aged ≥18 years diagnosed with shingles following screening based on ICD-10 codes. The prevalence of HZ infection was calculated; rates of HZ-related complications (recurrence, hospitalization, postherpetic neuralgia [PHN]) and associated risk factors were determined.</p><p><strong>Results: </strong>A total of 6114 HZ patients were included; the estimated 5-year HZ prevalence in Turkiye was 908.7 per 100,000 population. Of the patients, 851 (14.2%) were immunocompromised, 366 (6%) were hospitalized due to HZ, 284 (8.9%) experienced PHN, 97 (3.2%) experienced recurrence of the patients. Risk factors for PHN were older age (≥50 years [OR=3.19; p<0.001)], and trigeminal dermatome involvement (OR=2.45; p=0.006). Antiviral use was associated with reduced PHN risk (OR=0.16; p<0.001).</p><p><strong>Conclusions: </strong>Our multicenter cross-sectional study revealed the high burden of HZ in Türkiye and highlighted the potential for increasing prevalence due to risk factors including aging and comorbidities.</p>","PeriodicalId":14006,"journal":{"name":"International Journal of Infectious Diseases","volume":" ","pages":"108105"},"PeriodicalIF":4.3000,"publicationDate":"2025-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ijid.2025.108105","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: The study aimed to determine the estimated prevalence of herpes zoster (HZ) infection in the adult population in Türkiye and the rates of HZ-associated complications and risk factors.

Methods: This retrospective, multicenter (n=11), cross-sectional study was conducted between January 2016 and January 2022 and included all patients aged ≥18 years diagnosed with shingles following screening based on ICD-10 codes. The prevalence of HZ infection was calculated; rates of HZ-related complications (recurrence, hospitalization, postherpetic neuralgia [PHN]) and associated risk factors were determined.

Results: A total of 6114 HZ patients were included; the estimated 5-year HZ prevalence in Turkiye was 908.7 per 100,000 population. Of the patients, 851 (14.2%) were immunocompromised, 366 (6%) were hospitalized due to HZ, 284 (8.9%) experienced PHN, 97 (3.2%) experienced recurrence of the patients. Risk factors for PHN were older age (≥50 years [OR=3.19; p<0.001)], and trigeminal dermatome involvement (OR=2.45; p=0.006). Antiviral use was associated with reduced PHN risk (OR=0.16; p<0.001).

Conclusions: Our multicenter cross-sectional study revealed the high burden of HZ in Türkiye and highlighted the potential for increasing prevalence due to risk factors including aging and comorbidities.

评估基ye带状疱疹(带状疱疹)感染的临床特征、危险因素和预后:VARICOMP-Adult-2研究
目的:本研究旨在确定日本成年人群中带状疱疹(HZ)感染的估计患病率以及与HZ相关的并发症和危险因素的发生率。方法:这项回顾性、多中心(n=11)、横断面研究于2016年1月至2022年1月进行,纳入所有年龄≥18岁、根据ICD-10编码筛查后诊断为带状疱疹的患者。计算HZ感染流行率;测定hz相关并发症(复发、住院、带状疱疹后神经痛[PHN])及相关危险因素的发生率。结果:共纳入6114例HZ患者;土耳其5年HZ患病率估计为每10万人908.7例。其中免疫功能低下851例(14.2%),因HZ住院366例(6%),PHN 284例(8.9%),复发97例(3.2%)。结论:我们的多中心横断面研究揭示了基叶人HZ的高负担,并强调了由于年龄和合并症等危险因素导致患病率增加的可能性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
18.90
自引率
2.40%
发文量
1020
审稿时长
30 days
期刊介绍: International Journal of Infectious Diseases (IJID) Publisher: International Society for Infectious Diseases Publication Frequency: Monthly Type: Peer-reviewed, Open Access Scope: Publishes original clinical and laboratory-based research. Reports clinical trials, reviews, and some case reports. Focuses on epidemiology, clinical diagnosis, treatment, and control of infectious diseases. Emphasizes diseases common in under-resourced countries.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信